Published in J Mol Biol on July 29, 2011
Using a fragment-based approach to target protein-protein interactions. Chembiochem (2013) 1.09
Coarse grained models reveal essential contributions of topological constraints to the conformational free energy of RNA bulges. J Phys Chem B (2014) 0.95
Targeting HIV transcription: the quest for a functional cure. Curr Top Microbiol Immunol (2015) 0.85
Efficient in silico exploration of RNA interhelical conformations using Euler angles and WExplore. Nucleic Acids Res (2014) 0.82
A novel paramagnetic relaxation enhancement tag for nucleic acids: a tool to study structure and dynamics of RNA. ACS Chem Biol (2013) 0.80
Structure based approaches for targeting non-coding RNAs with small molecules. Curr Opin Struct Biol (2015) 0.79
Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors. Biology (Basel) (2012) 0.78
Distinct conformational transition patterns of noncoding 7SK snRNA and HIV TAR RNAs upon Tat binding. Biochemistry (2014) 0.77
The Emerging Role of RNA as a Therapeutic Target for Small Molecules. Cell Chem Biol (2016) 0.75
Amiloride as a new RNA-binding scaffold with activity against HIV-1 TAR. Medchemcomm (2017) 0.75
NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR (1995) 93.94
MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph (1996) 39.73
PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr (2004) 23.86
Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J Biomol NMR (1992) 17.71
The Xplor-NIH NMR molecular structure determination package. J Magn Reson (2003) 16.23
HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. J Am Chem Soc (2003) 11.65
Controlling the elongation phase of transcription with P-TEFb. Mol Cell (2006) 9.95
Conformation of the TAR RNA-arginine complex by NMR spectroscopy. Science (1992) 5.08
electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation. Acta Crystallogr D Biol Crystallogr (2009) 4.90
A decade of fragment-based drug design: strategic advances and lessons learned. Nat Rev Drug Discov (2007) 4.82
Control of RNA initiation and elongation at the HIV-1 promoter. Annu Rev Biochem (1994) 4.70
Recent developments in fragment-based drug discovery. J Med Chem (2008) 3.30
Tackling Tat. J Mol Biol (1999) 3.13
NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors. Angew Chem Int Ed Engl (2003) 2.98
The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein. J Mol Biol (1995) 2.93
Fragment-based lead discovery. Nat Rev Drug Discov (2004) 2.83
Structure of HIV-1 TAR RNA in the absence of ligands reveals a novel conformation of the trinucleotide bulge. Nucleic Acids Res (1996) 2.55
A robust method for determining the magnitude of the fully asymmetric alignment tensor of oriented macromolecules in the absence of structural information. J Magn Reson (1998) 2.38
Fragment-based drug discovery. J Med Chem (2004) 2.07
Role of RNA structure in arginine recognition of TAR RNA. Proc Natl Acad Sci U S A (1993) 1.94
Conformational inhibition of the hepatitis C virus internal ribosome entry site RNA. Nat Chem Biol (2009) 1.84
SAR by MS: discovery of a new class of RNA-binding small molecules for the hepatitis C virus: internal ribosome entry site IIA subdomain. J Med Chem (2005) 1.59
Solution structure of the HIV-2 TAR-argininamide complex. J Mol Biol (1997) 1.44
The bend in RNA created by the trans-activation response element bulge of human immunodeficiency virus is straightened by arginine and by Tat-derived peptide. Proc Natl Acad Sci U S A (1995) 1.38
Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots". J Mol Biol (2004) 1.37
Data-driven docking for the study of biomolecular complexes. FEBS J (2005) 1.37
Simultaneous recognition of HIV-1 TAR RNA bulge and loop sequences by cyclic peptide mimics of Tat protein. Proc Natl Acad Sci U S A (2009) 1.33
Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA. Chem Biol (2002) 1.30
Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA. J Mol Biol (2004) 1.29
Argininamide binding arrests global motions in HIV-1 TAR RNA: comparison with Mg2+-induced conformational stabilization. J Mol Biol (2004) 1.21
NMR-based characterization of phenothiazines as a RNA binding scaffold. J Am Chem Soc (2004) 1.17
TAR RNA recognition by a cyclic peptidomimetic of Tat protein. Biochemistry (2005) 1.09
Structure of TAR RNA complexed with a Tat-TAR interaction nanomolar inhibitor that was identified by computational screening. Chem Biol (2002) 1.06
SAR by ILOEs: an NMR-based approach to reverse chemical genetics. Chemistry (2006) 1.04
Discovery of aminoglycoside mimetics by NMR-based screening of Escherichia coli A-site RNA. J Am Chem Soc (2003) 1.02
Synthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNA. Chem Biol (2006) 1.01
Essential structural requirements for specific recognition of HIV TAR RNA by peptide mimetics of Tat protein. Nucleic Acids Res (2010) 1.00
Domain-elongation NMR spectroscopy yields new insights into RNA dynamics and adaptive recognition. RNA (2009) 0.96
SAR by MS: a ligand based technique for drug lead discovery against structured RNA targets. J Med Chem (2002) 0.95
TAR-RNA recognition by a novel cyclic aminoglycoside analogue. Nucleic Acids Res (2006) 0.93
The inter-ligand Overhauser effect: a powerful new NMR approach for mapping structural relationships of macromolecular ligands. J Biomol NMR (1999) 0.93
Design and implementation of an ribonucleic acid (RNA) directed fragment library. J Med Chem (2009) 0.89
Detecting ligand binding to a small RNA target via saturation transfer difference NMR experiments in D(2)O and H(2)O. J Am Chem Soc (2002) 0.88
Application of NMR SHAPES screening to an RNA target. J Am Chem Soc (2003) 0.88
Structure-activity relationships of aminoglycoside-arginine conjugates that bind HIV-1 RNAs as determined by fluorescence and NMR spectroscopy. FEBS Lett (2004) 0.84
Applications of SHAPES screening in drug discovery. Comb Chem High Throughput Screen (2002) 0.82
Tripeptides from synthetic amino acids block the Tat-TAR association and slow down HIV spread in cell cultures. Chembiochem (2007) 0.81
Heteronuclear correlation experiments for the determination of one-bond coupling constants. J Biomol NMR (1998) 0.81
Fragment-based discovery of novel thymidylate synthase leads by NMR screening and group epitope mapping. Chem Biol Drug Des (2010) 0.80
Flexibility of BIV TAR-Tat: models of peptide binding. J Biomol Struct Dyn (2002) 0.78
Structures of HIV TAR RNA-ligand complexes reveal higher binding stoichiometries. Chembiochem (2009) 0.77
Design of a novel globular protein fold with atomic-level accuracy. Science (2003) 13.06
RNA-binding proteins: modular design for efficient function. Nat Rev Mol Cell Biol (2007) 5.33
The structure and function of small nucleolar ribonucleoproteins. Nucleic Acids Res (2007) 2.50
Strong correlation between SHAPE chemistry and the generalized NMR order parameter (S2) in RNA. J Am Chem Soc (2008) 2.26
Recognition of GU-rich polyadenylation regulatory elements by human CstF-64 protein. EMBO J (2003) 2.01
Protein families and RNA recognition. FEBS J (2005) 1.65
The Cbf5-Nop10 complex is a molecular bracket that organizes box H/ACA RNPs. Nat Struct Mol Biol (2005) 1.52
High-resolution structural and thermodynamic analysis of extreme stabilization of human procarboxypeptidase by computational protein design. J Mol Biol (2006) 1.49
Structure of stem-loop IV of Tetrahymena telomerase RNA. EMBO J (2006) 1.49
The highly cooperative folding of small naturally occurring proteins is likely the result of natural selection. Cell (2007) 1.46
Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots". J Mol Biol (2004) 1.37
Simultaneous recognition of HIV-1 TAR RNA bulge and loop sequences by cyclic peptide mimics of Tat protein. Proc Natl Acad Sci U S A (2009) 1.33
Cooperative interaction of transcription termination factors with the RNA polymerase II C-terminal domain. Nat Struct Mol Biol (2010) 1.32
A conserved RNA structure within the HCV IRES eIF3-binding site. Nat Struct Biol (2002) 1.31
An all-atom, distance-dependent scoring function for the prediction of protein-DNA interactions from structure. Proteins (2007) 1.28
Structural genomics of infectious disease drug targets: the SSGCID. Acta Crystallogr Sect F Struct Biol Cryst Commun (2011) 1.27
A new hydrogen-bonding potential for the design of protein-RNA interactions predicts specific contacts and discriminates decoys. Nucleic Acids Res (2004) 1.27
A knowledge-based potential function predicts the specificity and relative binding energy of RNA-binding proteins. FEBS J (2007) 1.26
NMR studies of dynamics in RNA and DNA by 13C relaxation. Biopolymers (2007) 1.24
Combining functional and structural genomics to sample the essential Burkholderia structome. PLoS One (2013) 1.21
Structure-guided peptidomimetic design leads to nanomolar beta-hairpin inhibitors of the Tat-TAR interaction of bovine immunodeficiency virus. Biochemistry (2007) 1.20
How binding of small molecule and peptide ligands to HIV-1 TAR alters the RNA motional landscape. Nucleic Acids Res (2009) 1.20
The C-terminal domains of vertebrate CstF-64 and its yeast orthologue Rna15 form a new structure critical for mRNA 3'-end processing. J Biol Chem (2006) 1.20
Real-time multidimensional NMR follows RNA folding with second resolution. Proc Natl Acad Sci U S A (2010) 1.18
13C NMR relaxation studies of RNA base and ribose nuclei reveal a complex pattern of motions in the RNA binding site for human U1A protein. J Mol Biol (2005) 1.18
Hydration dependent dynamics in RNA. J Biomol NMR (2009) 1.17
A new alpha-helical extension promotes RNA binding by the dsRBD of Rnt1p RNAse III. EMBO J (2004) 1.12
Structural mimicry of retroviral tat proteins by constrained beta-hairpin peptidomimetics: ligands with high affinity and selectivity for viral TAR RNA regulatory elements. J Am Chem Soc (2004) 1.11
TAR RNA recognition by a cyclic peptidomimetic of Tat protein. Biochemistry (2005) 1.09
Structure and stability of wild-type and mutant RNA internal loops from the SL-1 domain of the HIV-1 packaging signal. J Mol Biol (2002) 1.07
How arginine-rich domains coordinate mRNA maturation events. RNA Biol (2007) 1.07
Protein and RNA dynamics play key roles in determining the specific recognition of GU-rich polyadenylation regulatory elements by human Cstf-64 protein. J Mol Biol (2005) 1.07
The solution structure of an essential stem-loop of human telomerase RNA. Nucleic Acids Res (2003) 1.06
Structural basis for stabilization of the tau pre-mRNA splicing regulatory element by novantrone (mitoxantrone). Chem Biol (2009) 1.06
The structure of an enzyme-activating fragment of human telomerase RNA. RNA (2005) 1.06
Engineering RNA-binding proteins for biology. FEBS J (2013) 1.06
γ-AApeptides bind to RNA by mimicking RNA-binding proteins. Org Biomol Chem (2011) 1.06
Validation of automated docking programs for docking and database screening against RNA drug targets. J Med Chem (2004) 1.05
Binding of U1A protein changes RNA dynamics as observed by 13C NMR relaxation studies. Biochemistry (2007) 1.05
Solid-state deuterium NMR studies reveal micros-ns motions in the HIV-1 transactivation response RNA recognition site. J Am Chem Soc (2008) 1.05
Essential structural requirements for specific recognition of HIV TAR RNA by peptide mimetics of Tat protein. Nucleic Acids Res (2010) 1.00
Novel protein-protein contacts facilitate mRNA 3'-processing signal recognition by Rna15 and Hrp1. J Mol Biol (2010) 1.00
The box H/ACA RNP assembly factor Naf1p contains a domain homologous to Gar1p mediating its interaction with Cbf5p. J Mol Biol (2007) 0.99
The Protein Maker: an automated system for high-throughput parallel purification. Acta Crystallogr Sect F Struct Biol Cryst Commun (2011) 0.99
Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNA. PLoS Pathog (2011) 0.97
High-resolution structural validation of the computational redesign of human U1A protein. Structure (2006) 0.96
Design of beta-hairpin peptidomimetics that inhibit binding of alpha-helical HIV-1 Rev protein to the rev response element RNA. Angew Chem Int Ed Engl (2007) 0.95
Monitoring tat peptide binding to TAR RNA by solid-state 31P-19F REDOR NMR. Nucleic Acids Res (2005) 0.94
Mitoxantrone analogues as ligands for a stem-loop structure of tau pre-mRNA. J Med Chem (2009) 0.94
Cell-free production of functional Plasmodium falciparum dihydrofolate reductase-thymidylate synthase. Mol Biochem Parasitol (2006) 0.93
Mis-translation of a computationally designed protein yields an exceptionally stable homodimer: implications for protein engineering and evolution. J Mol Biol (2006) 0.93
Structure of the yeast SR protein Npl3 and Interaction with mRNA 3'-end processing signals. J Mol Biol (2007) 0.93
13C relaxation studies of the DNA target sequence for hhai methyltransferase reveal unique motional properties. Biochemistry (2008) 0.91
The structure of a Burkholderia pseudomallei immunophilin-inhibitor complex reveals new approaches to antimicrobial development. Biochem J (2011) 0.91
Theory of nonrigid rotational motion applied to NMR relaxation in RNA. J Phys Chem A (2011) 0.91
A model for C74 addition by CCA-adding enzymes: C74 addition, like C75 and A76 addition, does not involve tRNA translocation. J Biol Chem (2006) 0.89
Intermediate rate atomic trajectories of RNA by solid-state NMR spectroscopy. J Am Chem Soc (2010) 0.89
Contrasting views of the internal dynamics of the HhaI methyltransferase target DNA reported by solution and solid-state NMR spectroscopy. J Am Chem Soc (2006) 0.87
The H/ACA RNP assembly factor SHQ1 functions as an RNA mimic. Genes Dev (2011) 0.87
How a rotavirus hijacks the human protein synthesis machinery. Nat Struct Biol (2002) 0.87
Slow exchange model of nonrigid rotational motion in RNA for combined solid-state and solution NMR studies. J Phys Chem B (2010) 0.86
Solution structure of the influenza A virus cRNA promoter: implications for differential recognition of viral promoter structures by RNA-dependent RNA polymerase. Nucleic Acids Res (2003) 0.85
Furanose dynamics in the HhaI methyltransferase target DNA studied by solution and solid-state NMR relaxation. J Phys Chem B (2008) 0.85
Multivalent drug design and inhibition of cholera toxin by specific and transient protein-ligand interactions. Chem Biol Drug Des (2008) 0.85
Molecular dynamics simulation of the RNA complex of a double-stranded RNA-binding domain reveals dynamic features of the intermolecular interface and its hydration. Biophys J (2002) 0.85
Identification of the optimal third generation antifolate against P. falciparum and P. vivax. Mol Biochem Parasitol (2005) 0.83
The box H/ACA snoRNP assembly factor Shq1p is a chaperone protein homologous to Hsp90 cochaperones that binds to the Cbf5p enzyme. J Mol Biol (2009) 0.83
Independent alignment of RNA for dynamic studies using residual dipolar couplings. J Biomol NMR (2012) 0.82
miRNA sensitivity to Drosha levels correlates with pre-miRNA secondary structure. RNA (2014) 0.82
Nop10 is a conserved H/ACA snoRNP molecular adaptor. Biochemistry (2008) 0.82
Decoding RNA motional codes. Trends Biochem Sci (2006) 0.82
Cell-free selection of RNA-binding proteins using in vitro compartmentalization. Nucleic Acids Res (2008) 0.82
A novel small-molecule binds to the influenza A virus RNA promoter and inhibits viral replication. Chem Commun (Camb) (2013) 0.82
Cardiomyocyte-specific expression of lamin a improves cardiac function in Lmna-/- mice. PLoS One (2012) 0.81
The interactome of the atypical phosphatase Rtr1 in Saccharomyces cerevisiae. Mol Biosyst (2014) 0.81
Examining the relationship between RNA function and motion using nuclear magnetic resonance. Wiley Interdiscip Rev RNA (2011) 0.81
13C/15N-19F intermolecular REDOR NMR study of the interaction of TAR RNA with Tat peptides. J Am Chem Soc (2010) 0.81
Finding the missing code of RNA recognition by PUF proteins. Chem Biol (2011) 0.81
Fragment-based discovery of novel thymidylate synthase leads by NMR screening and group epitope mapping. Chem Biol Drug Des (2010) 0.80
Differential drug binding by the highly conserved Plasmodium falciparum thymidylate synthase. Mol Biochem Parasitol (2005) 0.80
Structural and biochemical analysis of the assembly and function of the yeast pre-mRNA 3' end processing complex CF I. Proc Natl Acad Sci U S A (2012) 0.79
Predicting the success of fragment screening by X-ray crystallography. Methods Enzymol (2011) 0.79
Elucidating molecular motion through structural and dynamic filters of energy-minimized conformer ensembles. J Phys Chem B (2014) 0.79
Aminoglycoside antibiotics bind to the influenza A virus RNA promoter. Mol Biosyst (2012) 0.78
Molecular dynamics simulations identify time scale of conformational changes responsible for conformational selection in molecular recognition of HIV-1 transactivation responsive RNA. J Am Chem Soc (2014) 0.78
GFT projection NMR for efficient (1)H/ (13)C sugar spin system identification in nucleic acids. J Biomol NMR (2012) 0.77
Correction to "Theory of nonrigid rotational motion applied to NMR relaxation in RNA". J Phys Chem A (2012) 0.77
Multi-target parallel processing approach for gene-to-structure determination of the influenza polymerase PB2 subunit. J Vis Exp (2013) 0.77
Splicing factor 1 in the pocket. Structure (2003) 0.76
Structural biology: RNA switches function. Nature (2006) 0.76
Locking out viral replication. Nat Chem Biol (2009) 0.76
Preparation of RNA samples with narrow line widths for solid state NMR investigations. J Magn Reson (2012) 0.76
Cytidine derivatives as IspF inhibitors of Burkolderia pseudomallei. Bioorg Med Chem Lett (2013) 0.76
Comparative analysis of glutaredoxin domains from bacterial opportunistic pathogens. Acta Crystallogr Sect F Struct Biol Cryst Commun (2011) 0.75
Synthesis and biological evaluation of pyrazolopyrimidines as potential antibacterial agents. Bioorg Med Chem Lett (2015) 0.75
Interactions of protein side chains with RNA defined with REDOR solid state NMR. J Biomol NMR (2011) 0.75
Ultraslow Domain Motions in HIV-1 TAR RNA Revealed by Solid-State Deuterium NMR. J Phys Chem B (2016) 0.75